These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33340191)

  • 1. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
    Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
    J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
    Liaw J; Gorton S; Heal C; White A
    Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.
    Katzenellenbogen JM; Bond-Smith D; Ralph AP; Wilmot M; Marsh J; Bailie R; Matthews V
    Aust Health Rev; 2020 Apr; 44(2):212-221. PubMed ID: 32241338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
    Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
    BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory.
    Stewart T; McDonald R; Currie B
    Aust J Rural Health; 2007 Aug; 15(4):234-40. PubMed ID: 17617086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
    Kado J; Salman S; Hand R; O'Brien M; Ralph A; Bowen AC; Page-Sharp M; Batty KT; Dolman V; Francis JR; Carapetis J; Manning L
    J Antimicrob Chemother; 2022 Sep; 77(10):2679-2682. PubMed ID: 35822635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
    Haran S; Crane N; Kazi S; Axford-Haines L; White A
    Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine for pain-related distress in Aboriginal children on a penicillin regimen to prevent recurrence of rheumatic fever.
    Mitchell A; Kelly J; Cook J; Atkinson N; Spain B; Remenyi B; Wade V; Ralph AP
    Rural Remote Health; 2020 Nov; 20(4):5930. PubMed ID: 33147979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
    Gasse B; Baroux N; Rouchon B; Meunier JM; Frémicourt ID; D'Ortenzio E
    BMC Public Health; 2013 Feb; 13():131. PubMed ID: 23402561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
    Kevat PM; Reeves BM; Ruben AR; Gunnarsson R
    Curr Cardiol Rev; 2017; 13(2):155-166. PubMed ID: 28093988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
    Rémond MG; Coyle ME; Mills JE; Maguire GP
    Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.
    Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC
    Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study.
    Kado J; Salman S; Hla TK; Enkel S; Henderson R; Hand RM; Hort A; Page-Sharp M; Batty K; Moore BR; Bennett J; Anderson A; Carapetis J; Manning L
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0096223. PubMed ID: 37971244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
    Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia.
    Rémond MG; Severin KL; Hodder Y; Martin J; Nelson C; Atkinson D; Maguire GP
    Intern Med J; 2013 Apr; 43(4):386-93. PubMed ID: 22646671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
    Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.